BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 5,630.00
+40.00 (0.72%)
Last updated: Dec 5, 2025, 2:19 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 571.68 billion as of December 5, 2025. Its market cap has increased by 21.91% in one year.
Market Cap
571.68B
Enterprise Value
225.20B
Revenue
115.09B
Ranking
n/a
PE Ratio
4.86
Stock Price
5,630.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 571.68B, a decrease of -47.31%. That is a compound annual growth rate of -19.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 571.68B | 18.93% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8,911.91B |
| LigaChem Biosciences | 7,139.05B |
| Peptron | 6,540.52B |